Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
The European Heart Academy is delighted to announce an innovative programme, aiming to train the future leaders in arrhythmia management and research: “Diploma of Advanced Studies in Cardiac Arrhythmia Management” to start in October 2016. This advanced course is a joint collaboration between the Maastricht University Medical Centre, the European Heart Rhythm Association (EHRA) and the European Heart Academy (EHA).
Trans fatty acids (TFA) are widely recognized as the most harmful fat with regard to causing cardiovascular disease and the detrimental effects of TFA on heart health and mortality are now beyond dispute. Cardiovascular disease (CVD) is the main cause of death in Europe with very significant differences...
Cardiologists destined to become leaders in their hospital and in their specialty need to be equipped to answer difficult questions in an era one might term Big Cardiology. It’s an age in which quality is not just defined by whether a patient lives or...
This forum of Leadership & Management in Cardiovascular Medicine aim is to bring together health care professionals, manager,academics, decision and policy makers, as well as analysts, from a variety of geographical and institutional settings. This will be the opportunity to interact and exchange ideas, knowledge, experiences and best practices around health policy, health economics, health management, and health leadership matters.
Members of the European Heart Academy courses can benefit from a special fee.
The European Society of Cardiology supports the European Commission’s initiative to reform the existing EU framework on personal data protection to strengthen people’s rights, their ability to control their data and their capacity to exercise their rights more effectively.However, in line with the positions of the...
"Cardiovascular Disease (CVD) is the biggest killer in Europe, with a huge impact on the economy. It is our belief that public policies must be put in place to encourage its prevention. We have come to Brussels to be more active in the decision-making process.” - Professor Panos Vardas
The ESC opened the European Heart Agency in Brussels in February 2013, close to the European Parliament complex, as it is of vital importance to the ESC’s future to establish a base in the political capital of Europe.
Establishing the Brussels office is a very strong demonstration of the ESC’s determination to influence policies for the prevention of cardiovascular diseases with a presence at the centre of European politics.
From here, the members of this new facility will try to influence relevant aspects of policy and shape new projects that take us towards our mission of reducing the burden of cardiovascular disease. Apart from efficient secretarial support to all members, the Brussels office can accommodate board meetings, scientific events, webinars, and also meet a significant number of other needs. Press release: European Society of Cardiology opens Brussels bureau
The institute covers new ESC activities such as clinical trials, personalised medicine, novel technologies, quality assessment, and health care management. Find out more about theEuropean Heart Heath Institute
The European Heart Academy trains future leaders in cardiovascular medicine and offers courses for aspiring candidates that lead to academic degrees. Find out more about theEuropean Heart Academy
European Heart Agency29 square de Meeus4th FloorB-1000 BrusselsBelgiumPhone: +32 (0)2 274 10 70
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.